Aphakia Cataract
Ophthalmology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2025
2026
RxSightLight Adjustable lens
Clinical Trials (1)
Total enrollment: 500 patients across 1 trials
Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study
Start: Nov 2025Est. completion: Sep 2026500 patients
N/AEnrolling By Invitation
Related Jobs in Ophthalmology
Lead Data Manager
Genomics
Remote
6h ago
Cleanroom and Laboratory Technician
SAB BIO
7h ago
Clinical Operations Manager
Johnson & Johnson
Irvine, California, United States of America
23h ago
$117K - $201K/yr
Site Delivery Leader MLL
Johnson & Johnson
Gent, East Flanders, Belgium
23h ago
BM 喀什 PSR HY
Johnson & Johnson
Urumqi, Xinjiang, China
23h ago
Product Specialist
Johnson & Johnson
Hangzhou, Zhejiang, China
23h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space